Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes

Emanuela Napoleone, Angelomaria Di Santo, Marina Camera, Elena Tremoli, Roberto Lorenzet

Research output: Contribution to journalArticle

Abstract

Angiotensin-converting enzyme (ACE) inhibitors reduce the risk of recurrent myocardial infarction in patients with left ventricular dysfunction. Tissue factor (TF), the initiator of blood coagulation, plays a pivotal role in arterial thrombosis that occurs after atherosclerotic plaque fissuring. Because monocytes synthesize TF and contain several components of the renin-angiotensin system, we investigated the possibility that ACE inhibitors could modulate monocyte TF expression. Mononuclear leukocytes from healthy volunteers were incubated with endotoxin in the presence or absence of different ACE inhibitors. Captopril reduced TF expression in endotoxin- stimulated mononuclear leukocytes, as measured by a 1-stage clotting assay and ELISA analysis, by ≃60%. The effect was dose-dependent and was attributable to ACE inhibition, given that other ACE inhibitors, such as idrapril or fosinopril, and losartan, an antagonist of the angiotensin II AT 1 receptor, caused a comparable reduction in TF activity. Reverse transcriptase-polymerase chain reaction indicated that endotoxin-mediated increased levels of TF mRNA were inhibited by ACE inhibitors. Moreover, endotoxin-induced nuclear factor-κB translocation to the promoter region of the gene encoding for TF was markedly inhibited by captopril. The finding that ACE inhibitors and angiotensin II AT 1 antagonists can potentially modulate TF expression by mononuclear cells has important biological and therapeutic implications for the evolution of thrombi. Our results suggest that the anti-ischemic effect of these drugs might be explained, at least in part, by their ability to reduce TF expression in monocytes.

Original languageEnglish
Pages (from-to)139-143
Number of pages5
JournalCirculation Research
Volume86
Issue number2
Publication statusPublished - 2000

Fingerprint

Thromboplastin
Angiotensin-Converting Enzyme Inhibitors
Monocytes
Down-Regulation
Endotoxins
Mononuclear Leukocytes
Captopril
Angiotensin II
Thrombosis
Fosinopril
Losartan
Left Ventricular Dysfunction
Blood Coagulation
Peptidyl-Dipeptidase A
Atherosclerotic Plaques
Renin-Angiotensin System
Reverse Transcriptase Polymerase Chain Reaction
Genetic Promoter Regions
Healthy Volunteers
Enzyme-Linked Immunosorbent Assay

Keywords

  • Angiotensin
  • Coagulation
  • Leukocyte

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes. / Napoleone, Emanuela; Di Santo, Angelomaria; Camera, Marina; Tremoli, Elena; Lorenzet, Roberto.

In: Circulation Research, Vol. 86, No. 2, 2000, p. 139-143.

Research output: Contribution to journalArticle

Napoleone, Emanuela ; Di Santo, Angelomaria ; Camera, Marina ; Tremoli, Elena ; Lorenzet, Roberto. / Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes. In: Circulation Research. 2000 ; Vol. 86, No. 2. pp. 139-143.
@article{fb4fd3efa5b14317bd646a48c3e2d783,
title = "Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes",
abstract = "Angiotensin-converting enzyme (ACE) inhibitors reduce the risk of recurrent myocardial infarction in patients with left ventricular dysfunction. Tissue factor (TF), the initiator of blood coagulation, plays a pivotal role in arterial thrombosis that occurs after atherosclerotic plaque fissuring. Because monocytes synthesize TF and contain several components of the renin-angiotensin system, we investigated the possibility that ACE inhibitors could modulate monocyte TF expression. Mononuclear leukocytes from healthy volunteers were incubated with endotoxin in the presence or absence of different ACE inhibitors. Captopril reduced TF expression in endotoxin- stimulated mononuclear leukocytes, as measured by a 1-stage clotting assay and ELISA analysis, by ≃60{\%}. The effect was dose-dependent and was attributable to ACE inhibition, given that other ACE inhibitors, such as idrapril or fosinopril, and losartan, an antagonist of the angiotensin II AT 1 receptor, caused a comparable reduction in TF activity. Reverse transcriptase-polymerase chain reaction indicated that endotoxin-mediated increased levels of TF mRNA were inhibited by ACE inhibitors. Moreover, endotoxin-induced nuclear factor-κB translocation to the promoter region of the gene encoding for TF was markedly inhibited by captopril. The finding that ACE inhibitors and angiotensin II AT 1 antagonists can potentially modulate TF expression by mononuclear cells has important biological and therapeutic implications for the evolution of thrombi. Our results suggest that the anti-ischemic effect of these drugs might be explained, at least in part, by their ability to reduce TF expression in monocytes.",
keywords = "Angiotensin, Coagulation, Leukocyte",
author = "Emanuela Napoleone and {Di Santo}, Angelomaria and Marina Camera and Elena Tremoli and Roberto Lorenzet",
year = "2000",
language = "English",
volume = "86",
pages = "139--143",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes

AU - Napoleone, Emanuela

AU - Di Santo, Angelomaria

AU - Camera, Marina

AU - Tremoli, Elena

AU - Lorenzet, Roberto

PY - 2000

Y1 - 2000

N2 - Angiotensin-converting enzyme (ACE) inhibitors reduce the risk of recurrent myocardial infarction in patients with left ventricular dysfunction. Tissue factor (TF), the initiator of blood coagulation, plays a pivotal role in arterial thrombosis that occurs after atherosclerotic plaque fissuring. Because monocytes synthesize TF and contain several components of the renin-angiotensin system, we investigated the possibility that ACE inhibitors could modulate monocyte TF expression. Mononuclear leukocytes from healthy volunteers were incubated with endotoxin in the presence or absence of different ACE inhibitors. Captopril reduced TF expression in endotoxin- stimulated mononuclear leukocytes, as measured by a 1-stage clotting assay and ELISA analysis, by ≃60%. The effect was dose-dependent and was attributable to ACE inhibition, given that other ACE inhibitors, such as idrapril or fosinopril, and losartan, an antagonist of the angiotensin II AT 1 receptor, caused a comparable reduction in TF activity. Reverse transcriptase-polymerase chain reaction indicated that endotoxin-mediated increased levels of TF mRNA were inhibited by ACE inhibitors. Moreover, endotoxin-induced nuclear factor-κB translocation to the promoter region of the gene encoding for TF was markedly inhibited by captopril. The finding that ACE inhibitors and angiotensin II AT 1 antagonists can potentially modulate TF expression by mononuclear cells has important biological and therapeutic implications for the evolution of thrombi. Our results suggest that the anti-ischemic effect of these drugs might be explained, at least in part, by their ability to reduce TF expression in monocytes.

AB - Angiotensin-converting enzyme (ACE) inhibitors reduce the risk of recurrent myocardial infarction in patients with left ventricular dysfunction. Tissue factor (TF), the initiator of blood coagulation, plays a pivotal role in arterial thrombosis that occurs after atherosclerotic plaque fissuring. Because monocytes synthesize TF and contain several components of the renin-angiotensin system, we investigated the possibility that ACE inhibitors could modulate monocyte TF expression. Mononuclear leukocytes from healthy volunteers were incubated with endotoxin in the presence or absence of different ACE inhibitors. Captopril reduced TF expression in endotoxin- stimulated mononuclear leukocytes, as measured by a 1-stage clotting assay and ELISA analysis, by ≃60%. The effect was dose-dependent and was attributable to ACE inhibition, given that other ACE inhibitors, such as idrapril or fosinopril, and losartan, an antagonist of the angiotensin II AT 1 receptor, caused a comparable reduction in TF activity. Reverse transcriptase-polymerase chain reaction indicated that endotoxin-mediated increased levels of TF mRNA were inhibited by ACE inhibitors. Moreover, endotoxin-induced nuclear factor-κB translocation to the promoter region of the gene encoding for TF was markedly inhibited by captopril. The finding that ACE inhibitors and angiotensin II AT 1 antagonists can potentially modulate TF expression by mononuclear cells has important biological and therapeutic implications for the evolution of thrombi. Our results suggest that the anti-ischemic effect of these drugs might be explained, at least in part, by their ability to reduce TF expression in monocytes.

KW - Angiotensin

KW - Coagulation

KW - Leukocyte

UR - http://www.scopus.com/inward/record.url?scp=0033960710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033960710&partnerID=8YFLogxK

M3 - Article

C2 - 10666408

AN - SCOPUS:0033960710

VL - 86

SP - 139

EP - 143

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 2

ER -